2025
Dr. Julia Gierlinger (geb. Holzgruber)
Type I interferon signaling induces melanoma cell-intrinsic PD-1 and ist inhibition antagonizes immune checkpoint blockade
2023
Dr.med.univ. Johanna Strobl, Wien
Diverse macrophage populations contribute to distinct manifestations of human cutaneous graft-versus-host disease
Dr. med.univ. Tobias Welponer Fries, Salzburg
Metformin shows anti-neoplastic properties by inhibition of oxidative phosphorylation and glycolysis in epidermolysis bullosa-associated aggressive cutaneous squamous cell carcinoma
